Patents by Inventor Jean Montel

Jean Montel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained-release pharmaceutical formulations containing mizolastine
    Publication number: 20050202089
    Abstract: A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.
    Type: Application
    Filed: January 3, 2005
    Publication date: September 15, 2005
    Applicant: SANOFI-SYNTHELABO
    Inventors: Maryvonne Chariot, Gareth Lewis, Jean Montel
  • Slow-release pharmaceutical formulations containing mizolastine
    Patent number: 6165507
    Abstract: A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: December 26, 2000
    Assignee: Synthelabo
    Inventors: Maryvonne Chariot, Gareth Lewis, Jean Montel
  • Pharmaceutical compositions containing amisulpride and their therapeutic applications
    Patent number: 6069165
    Abstract: A pharmaceutical composition, comprising a lipophilic phase and, as active principle, at least one compound selected froman optically active isomer or a racemate of amisulpride;an optically active isomer or a racemate of a pharmaceutically acceptable acid addition salt of amisulpride;an optically active isomer or a racemate of a quaternary ammonium salt of amisulpride; andan optically active isomer or a racemate of an oxide of amisulpride.
    Type: Grant
    Filed: March 16, 1999
    Date of Patent: May 30, 2000
    Assignee: Synthelabo
    Inventors: Veronique Andrieu, Alain Cuine, Jean Montel
  • Concentrated aqueous solutions of argatroban
    Patent number: 5679690
    Abstract: Concentrated aqueous solutions of argatroban containing argatroban, a micelle-forming agent and a lipoid substance.
    Type: Grant
    Filed: February 2, 1995
    Date of Patent: October 21, 1997
    Assignee: Synthelabo
    Inventors: Frederic Andre, Veronique Avril, Jean Montel
  • Sustained-release compositions of alfuzosin hydrochloride
    Patent number: 5589190
    Abstract: Pharmaceutical compositions which comprises a core comprising alfuzosin hydrochloride which core is coated with a coating whose dissolution is pH-dependent and applications to the preparation of sustained-release dosage compositions which are unable for a once-daily oral administration.
    Type: Grant
    Filed: March 20, 1995
    Date of Patent: December 31, 1996
    Assignee: Synthelabo
    Inventors: Veronique Andrieu, Jean Montel, Alexander Wick
  • Transdermal pharmaceutical composition
    Patent number: 5523094
    Abstract: A pharmaceutical preparation intended for transdermal administration contains alfusozin [(N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydr o-2-furancarboxamide] or a salt thereof and a mixture composed of water, at least one organic solvent and at least one absorption promoter.
    Type: Grant
    Filed: July 20, 1994
    Date of Patent: June 4, 1996
    Assignee: Synthelabo
    Inventors: Veronique Andrieu, Louis Henrion, Jean Montel, Alexander Wick